Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8168757 PD-1 binding proteins

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 3, 2009
Date of Patent
May 1, 2012
Patent Application Number
12922066
Patent Citations Received
‌
US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
‌
US Patent 12090147 Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 12103954 Heterodimeric Fc cytokines and uses thereof
0
‌
US Patent 11654193 Cancer treatment combinations
0
‌
US Patent 11667635 Bicyclic heterocycles as FGFR4 inhibitors
0
‌
US Patent 11667890 Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
0
‌
US Patent 11673894 Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
0
‌
US Patent 11685761 Cyclic di-nucleotide compounds as sting agonists
0
‌
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8168757
Patent Primary Examiner
‌
Ilia Ouspenski

Find more entities like US Patent 8168757 PD-1 binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo